The combined treatment of aspirin and radiation induces apoptosis by the regulation of bcl-2 and caspase-3 in human cervical cancer cell

Cancer Letters

Volumn 189, Issue 2, 2003, Pages 157-166

  Kim, Kye Young ^a   Seol, Ji Yeon ^a   Jeon, Geong A ^b   Nam, Myeong Jin ^a  

^a Korea National Institute of Health   (South Korea)

^b Seoulin Bioscience Co Ltd   (South Korea)

Author keywords

Apoptosis; Cervical cancer; Combined therapy; Nonsteroidal anti inflammatory drugs; NSAIDs; Radiation

Indexed keywords

ACETYLSALICYLIC ACID; CASPASE 3; HOE 33342; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN BCL 2; PROTEIN P53; SULINDAC;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASSAY; CANCER CELL; CELL LINE; CELL PROLIFERATION; CELL SUBPOPULATION; COLONY FORMATION; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION; RADIATION DOSE; UTERINE CERVIX CANCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ASPIRIN; CASPASE 3; CASPASES; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GAMMA RAYS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; GENES, P53; HELA CELLS; HUMANS; INDOMETHACIN; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; SULINDAC; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037469078     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00519-0     Document Type: Article

References (32)

1. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., Kliewer S.A. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272:1997;3406-3410.
2. Chan T.A., Morin P.J., Vogelstein B., Kinzler K.W. Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis. Proc. Natl. Acad. Sci. USA. 95:1998;681-686.
3. Dbaibo G.S., Pushkareva M.Y., Rachid R.A., Alter N., Smyth M.J., Obeid L.M., Hannun Y.A. p53-dependent ceramide response to genotoxic stress. J. Clin. Invest. 10:1998;329-339.
4. Elder D.J.E., Hague A., Hicks D.J., Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res. 56:1996;2273-2276.
5. Shiff S.J., Rigas B. The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal anti-inflammatory drugs (NSAIDs). J. Exp. Med. 190:1999;445-450.
6. Shiff S.J., Koutsos M.I., Qiao L., Rigas B. Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp. Cell Res. 222:1996;179-188.
7. Yamamoto Y., Yin M.J., Lin K.M., Gaynor R.B. Sulindac inhibits activation of the NF-κB pathway. J. Biol. Chem. 274:1999;27307-27314.
8. Filippovich I.V., Sorokina N.I., Lisbona A., Cherel M., Chatal J.F. Radiation-induced apoptosis in human myeloma cell line increases BCL-2/BAX dimer formation and does not result in BAX/BAX homodimerization. Int. J. Cancer. 92:2001;651-660.
9. Johnson M.D., Xiang H., London S., Kinoshita Y., Knudson M., Mayberg M., Korsmeyer S.J., Morrison R.S. Evidence for involvement of Bax and p53, but not caspases, in radiation-induced cell death of cultured postnatal hippocampal neurons. J. Neurosci. Res. 54:1998;721-733.
10. Yu Y., Little J.B. p53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines. Cancer Res. 58:1998;4277-4281.
11. Ohno T., Nakano T., Niibe Y., Tsujii H., Oka K. Bax protein expression correlates with radiation-induced apoptosis in radiation therapy for cervical cancer. Cancer. 83:1998;103-110.
12. Chinnaiyan A.M., Prasad U., Shankar S., Hamstra D.A., Shanaiah M., Chenevert T.L., Ross B.D., Rehemtulla A. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc. Natl. Acad. Sci. USA. 97:2000;1754-1759.
13. Mauceri H.J., Hanna N.N., Beckett M.A., Gorski D.H., Staba M.J., Stellato K.A., Bigelow K., Heimann R., Gately S., Dhanabal M., Soff G.A., Sukhatme V.P., Kufe D.W., Weichselbaum R.R. Combined effects of antistatic and ionizing radiation in antitumor therapy. Nature. 394:1998;287-291.
14. Palayoor S.T., Bump E.A., Calderwood S.K., Bartol S., Coleman C.N. Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells. Clin. Cancer Res. 4:1998;763-771.
15. Dicker A.P., Williams T.L., Grant D.S. Targeting angiogenic processes by combination rofecoxib and ionizing radiation. Am. J. Clin. Oncol. 24:2001;438-442.
16. Milas L., Ito H., Nakayama T., Hunter N. Improvement in therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus misonidazole. Cancer Res. 51:1991;3639-3642.
17. Reddy B.S., Kawamori T., Lubet R.A., Steele V.E., Kelloff G.J., Rao C.V. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Res. 59:1999;3387-3391.
18. Ahnen D.J. Colon cancer prevention by NSAIDs: what is the mechanism of action? Eur. J. Surg. Suppl. 582:1998;111-114.
19. Rahman M.A., Dhar D.K., Masunaga R., Yamanoi A., Kohno H., Nagasue N. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines. Cancer Res. 60:2000;2085-2089.
20. Zhou X.M., Wong B.C., Fan X.M., Zhang H.B., Lin M.C., Kung H.F., Fan D.M., Lam S.K. Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis. 22:2001;1393-1397.
21. Alpert D., Vilcek J. Inhibition of IκB kinase activity by sodium salicylate in vitro does not reflect its inhibitory mechanism in intact cells. J. Biol. Chem. 275:2000;10925-10929.
22. Tanaka H., Arakawa H., Yamaguchi T., Shiraishi K., Fukuda S., Matsui K., Takei Y., Nakamura Y. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature. 404:2000;42-49.
23. Williams C.S., Smalley W., Dubois R.N. Aspirin use and potential mechanisms for colorectal cancer prevention. J. Clin. Invest. 100:1997;1325-1329.
24. 3). FEBS Lett. 519:2002;195-200.
25. Eiseman J.L., Rogers F.A., Guo Y., Kauffman J., Sentz D.L., Klinger M.F., Callery P.S., Kyprianou N. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer. Cancer Res. 58:1998;4864-4870.
26. Rupnow B.A., Murtha A.D., Alarcon R.M., Giaccia A.J., Knox S.J. Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy. Cancer Res. 58:1998;1779-1784.
27. Vaux D.L., Strasser A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;2239-2244.
28. Xu X.M., Sansores-Garcia L., Chen X.M., Matijevic-Aleksic N., Du M., Wu K.K. Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc. Natl. Acad. Sci. USA. 96:1999;5292-5297.
29. Kalgutkar A.S., Crews B.C., Rowlinson S.W., Garner C., Seibert K., Marnett L.J. Aspirin-like molecules that covalently inactivate cyclooxygenase-2. Science. 280:1998;1268-1270.
30. Meade E.A., Smith W.L., Dewitt D.L. Differential inhibition of endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268:1993;6610-6614.
31. Piazza G.A., Rahm A.K., Finn T.S., Fryer B.H., Li H., Stoumen A.L., Pamukcu R., Ahnen D.J. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res. 57:1997;2452-2459.
32. Kessis T.D., Slebos R.J., Nelson W.G., Kastan M.B., Plunkett B.S., Han S.M., Lorincz A.T., Hedrick L. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA. 90:1993;3988-3992.